Vita Coco Q2 Earnings Beat: EPS $0.82 vs $0.56 Est.

What happened

Vita Coco reported Q2 earnings of $0.82 per share, crushing the consensus estimate of $0.56 and more than doubling the prior-year's $0.38, driven by strong branded coconut water volume growth and the national rollout of Vita Coco Treats. Despite the headline beat, gross margins contracted to ~37% from ~40% a year ago, as newly implemented U.S. tariffs, higher freight costs, and input inflation squeezed profitability. The company's asset-light model and net cash position provide liquidity, but the blended tariff rate of ~23% on key sourcing regions (Brazil, Southeast Asia) remains a structural overhang. Meanwhile, the stock trades at over 40x trailing earnings and ~15x EV/EBITDA, leaving little margin of safety even after this earnings upside. The Q2 results underscore robust top-line momentum, but the underlying margin erosion and premium valuation keep the risk/reward skewed to the downside.

Implication

The Q2 beat is a positive short-term catalyst, but it does not change the structural challenges we flagged: tariffs are compressing gross margins toward the mid-30% range, competition is intensifying in the maturing coconut water category, and the stock at ~44x trailing earnings capitalizes growth that may not materialize if input costs remain elevated. While the company has a net cash balance sheet and active buybacks, these provide limited downside protection if margins deteriorate further. The earnings overshoot could even reinforce complacency, as investors may overlook the widening gap between operational performance and DCF-based intrinsic value (~$16 per share). For now, the thesis remains cautious: wait for a larger margin of safety or evidence of sustained tariff relief before moving from sell to neutral.

Thesis delta

The Q2 earnings beat adds near-term credibility to Vita Coco's growth narrative, but it does not alleviate the fundamental overvaluation and tariff risks that underpin our POTENTIAL SELL stance. If margins continue to slip or tariffs persist, the current premium multiple is unsustainable; if tariffs are removed or margins recover unexpectedly, the stance could shift to WAIT. Until then, the risk/reward remains unfavorable.